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Selected abstracts from the 34th Annual Spring Meeting of the Korean Society of Nephrology 2014 A7whether a dipeptidyl peptidase (DPP) IV inhibitor is effective in
improving TAC-induced diabetes mellitus by reducing pancreatic
islet injury.
Methods: Rats were treated with TAC (1.5 mg/kg, subcuta-
neously) and DPP IV inhibitor MK-0626 (10 or 20 mg/kg, oral
gavage) for 4 weeks. The effect of MK-0626 on TAC-induced
diabetes was evaluated by assessing pancreatic islet function,
histopathology. TAC-induced incretin dysfunction was also
examined with the serum active glucagon like peptide (GLP)-1
level after glucose loading. Protective effect of MK-0626 was
evaluated by measuring markers for oxidative stress, oxidative
resistance, and apoptosis. To reveal whether enhanced GLP-1
signaling is associated with these protective effects, we mea-
sured the expression of GLP-1 receptor (GLP-1R) and effect of
GLP-1 analogue exendin-4 on cell viability and oxidative stress in
isolated islets.
Results: MK-0626 treatment attenuated TAC-induced pancreatic
islet dysfunctions and islet morphology. TAC treatment showed
defective in active GLP-1 secretion; however, MK-0626 recovered
these effects. TAC treatment increased the level of 8-hydroxy-
2’deoxyguanosine (8-OHdG), number of apoptotic cell death,
active caspase-3 and decreased the level of manganese super-
oxide dismutase and heme oxygenase-1, and MK-0626 treatment
reversed these changes. MK-0626 treatment restored the expres-
sion of GLP-1R and direct exendin-4 treatment in isolated islet
reduced TAC-induced cell death and 8-OHdG expression.
Conclusions: DPP IV inhibitor MK-0626 is an effective anti-
diabetic agent with antioxidative and antiapoptotic properties
by enhanced GLP-1 signaling in TAC-induced diabetics. These
beneﬁcial effects of DPP IV inhibitor could be helpful to a delay in
the new onset of diabetes in transplant recipients.
http://dx.doi.org/10.1016/j.krcp.2014.05.028
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Blocking of proinﬂammatory cytokine, interleukin-6 (IL-6) is
effective in decreasing resistance to allogenic tolerance. In this
study, we investigated whether anti-IL-6 receptor producing
nonviral minicircle (MC)-DNA, is competent to inhibit
alloresponse-induced IL-6 in highly immunogenic murine skin
allograft model. We designed MC-DNA producing IL-6R antibody
and veriﬁed in vitro system. One day before skin allograft
modeling, systemic MC-DNA exposed via hydrodynamic delivery
of MC-DNA in vivo (50 ug of DNA, tail vein, single injection).
Using GFP tagging MC-DNA, we conﬁrmed its organ distribution.
At day 5, we measured the amount of IL-6 and IL-6R antibody in
serum. As functional examinations, we evaluated survival rate,
morphological changes of graft, immune cell inﬁltration, and
population of T helper 17 cells (Th17, FACS marker: CD4þ/RoRγt)
and regulatory T cells (Treg, FACS marker: CD4þ Foxp3þ). We
compared its alloimmunity and graft survival efﬁciency with the
cyclosporine A (CsA)-treated group (50 mg/kg, daily administra-
tion via oral gavage). Hydrodynamic delivery of MC-DNA was
mainly localized in hepatocytes. Serum IL-6 and IL-6R antibody
detected in anti-IL-6R MC-DNA treated mice. At day 8.5,
untreated mice completely rejected the graft conﬁrming by daily
observation of loss of skin graft and erosion. However, mice
received either anti-IL-6R MC-DNA or CsA presented prolonged
acceptance of graft until day 15 or 15.6, respectively. Results from
morphological changes and immune cell inﬁltration in the graft
were also consistent with survival rate. FACS results showed that
anti-IL-6R MC-DNA treatment markedly suppressed Th17 popu-
lation compared with the untreated mice. However, there was no
effect on Treg population. On the other hand, administration of
CsA showed the increased Th17 and decreased Treg population
compared with untreated group. We found that single injection
of nonviral minicircle DNA targeting IL-6R is effective in both
acute allograft acceptance and allogenic tolerance. This suggests
that simple and effective gene therapy method using antibody
producing minicircle DNA may represent a powerful tool for the
transplantation.http://dx.doi.org/10.1016/j.krcp.2014.05.029& 2014. The Korean Society of Nephrology. Published by Elsevier. All
rights reserved.
